TOKYO, Aug 1 (Reuters) - A Japanese health ministry panel recommended approval for Daiichi Sankyo's (4568.T) mRNA-based COVID-19 vaccine in what would be the nation's first home-grown shot for the coronavirus.

Daiichi Sankyo submitted the vaccine, known as DS-5670 with the brand name Daichirona, to regulators in January, proposing the shot as a booster after regular immunisation.

The decision by the expert panel, delivered on Monday evening, sets up the vaccine for full approval by the government.